Covered recipient · General Payments record
JOAN SCHILLER
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$117,206.90
- Reported across 96 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $20,564.50 | 12 |
| Food and Beverage | $39.07 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $11,180.00 | 7 |
| AstraZeneca UK Limited | $5,274.50 | 4 |
| Daiichi Sankyo Inc. | $4,110.00 | 1 |
| Janssen Biotech, Inc. | $39.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca UK Limited | $1,370.00 | 04/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1094050713 | CMS |
| AstraZeneca UK Limited | $1,164.50 | 05/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093987425 | CMS |
| AstraZeneca UK Limited | $685.00 | 06/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1094008284 | CMS |
| AstraZeneca UK Limited | $2,055.00 | 08/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1094023236 | CMS |
| Daiichi Sankyo Inc. | $4,110.00 | 09/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089479325 | CMS |
| Janssen Biotech, Inc. | $39.07 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078705976 | CMS |
| Merck Sharp & Dohme LLC | $457.50 | 01/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141702781 | CMS |
| Merck Sharp & Dohme LLC | $3,690.00 | 03/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141831445 | CMS |
| Merck Sharp & Dohme LLC | $3,205.00 | 06/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141581431 | CMS |
| Merck Sharp & Dohme LLC | $2,455.00 | 09/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141595486 | CMS |
| Merck Sharp & Dohme LLC | $305.00 | 12/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141581433 | CMS |
| Merck Sharp & Dohme LLC | $762.50 | 12/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141581435 | CMS |
| Merck Sharp & Dohme LLC | $305.00 | 12/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141581437 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.